Karen Fernandez, MD, discusses the different types of treatment currently being tested for use in dry eye disease, which affects millions in the US.
New treatments are currently being tested in clinical trials for use in dry eye, according to Karen Fernandez, MD, ophthalmologist at the Storm Eye Institute at the Medical University of South Carolina. These include a blood serum eye drop and prescription contact lenses.
This transcript has been lightly edited; captions are auto-generated.
Transcript
Are there currently any new dry eye treatments in development?
There are some things on the horizon. It's very exciting and hopefully will be with us soon. One is the use of biologic drops. These are drops made from, for example, the patient's own blood serum. This is a fluid that comes from patient's own blood, and it's gets compounded to an eye drop. The theory is that the blood has a lot of what the surface of the eye needs, including proteins, vitamins, growth factors that keep the surface of the eye healthy. We also use amniotic fluid that is then turned into eye drops, and that can also be something that can help with the surface. Bhese 2 things are currently still under investigation. We do already prescribe them, and we all think it's a very acceptable treatment for dry eye. However, there are still a lot of studies that need to be done with these eye drops. There are also improvements in drug delivery systems, including implants that are slow release in the eye, or medicated contact lenses that make treatment a little bit more convenient and easier for patients, and results [in] more consistency in using these drops. There are also neuromodulators that are on the horizon, and this is making use of nerve stimulants to hopefully stimulate the eye to heal itself, as well as increase tear production. Those are the things to look forward to.
There is actually a nasal spray that you can use for dry eye, and it stimulates the nerves within the eye to help produce tears. Those are things that are currently new to the market, new to the treatment. A lot of studies going on about them and seeing if they are effective or they can be part of the protocol for dry eye treatment. But it's very exciting and hopefully we get to see these things come about and we can offer them to patients.
Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia
August 20th 2025Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and data-driven strategies in Philadelphia, Pennsylvania, and Wilmington, Delaware, for sustainable health programs.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More